Evidence Development Gets Title Role In CMS Coverage Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
CMS further advanced its budding policy for conditioning Medicare coverage on evidence collection by expanding the 1charter of a key advisory committee last week
You may also be interested in...
Advisory Panel Conflict Waivers To Stay; FDA Will Provide Clarity On Process
FDA's plan for improving its advisory committee member selection process focuses on increasing the transparency and consistency of the existing process rather than a more extensive overhaul
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance
CMS introduces two distinct categories of coverage-with-evidence-development determinations in long-awaited 1guidelines issued July 12
CMS Expands ICD Coverage In Long-Awaited Decision; Stakeholders Rejoice
CMS' expansion of implantable cardioverter defibrillator Medicare coverage incorporates several recommendations from manufacturers and professional societies